Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats

Diabetes

Volumn 49, Issue 2, 2000, Pages 244-252

  Havel, Peter J ^a   Hahn, Tina M ^b   Sindelar, Dana K ^b   Baskin, Denis G ^b   Dallman, Mary F ^c   Weigle, David S ^b   Schwartz, Michael W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN RELEASING FACTOR; INSULIN; LEPTIN; MELANOCORTIN; MELANOCORTIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; RECEPTOR ANTIBODY; STREPTOZOCIN; UNCOUPLING PROTEIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY METABOLISM; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HYPERGLYCEMIA; HYPERPHAGIA; IN SITU HYBRIDIZATION; INSULIN TREATMENT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033969423     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.2.244     Document Type: Article

References (72)

1. Kumaresan P, Turner CW: Effect of alloxan on feed consumption and on replacement therapy with graded levels of insulin in rats. Proc Soc Exp Biol Med 122:526-527, 1966
2. Boothe DA: Characteristics of feeding during streptozotocin-induced diabetes in the rat. J Comp Physiol Psych 2:1238-1240, 1972
3. Havel RJ: Caloric homeostasis and disorders of fuel transport. N Engl J Med 287:1186-1192, 1972
4. Randle PJ: Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14:263-283, 1998
5. Woods SC, Chavez M, Park CR, Riedy C, Kaiyala K, Richardson RD, Figlewicz DP, Schwartz MW, Porte D, Seeley RJ: The evaluation of insulin as a metabolic signal influencing behavior via the brain. Neurosci Biobehav Rev 20:139-144, 1996
6. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 395:763-770, 1998
7. Havel PJ: Mechanisms regulating leptin production and action: implications for control of energy balance. Am J Clin Nutr 70:305-306, 1999
8. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans New Engl J Med 334:292-295, 1996
9. Havel PJ, Kasim-Karakas S, Mueller WM, Johnson PR, Gingerich RL, Stern JS: Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab 81:4406-4413, 1996
10. Weigle DS, Duell PB, Connor WE, Steiner RA, Soules MR, Kuijper JL: Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 82:561-565, 1997
11. Dubuc GR Phinney SD, Stern JS, Havel PJ: Changes of serum leptin and endocrine and metabolic parameters after 7 days energy restriction in men and women. Metabolism 47:429-434, 1998
12. Havel, PJ, Townsend R, Chaump L, Teff K: High fat meals reduce 24 h circulating leptin concentrations in women. Diabetes 48:334-341, 1999
13. Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen CL, Ahren B: Rapid and marked decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol 274:R1482-R1491, 1998
14. Sivitz WI, Walsh S, Morgan D, Donohue P, Haynes W, Leibel RL: Plasma leptin in diabetic and insulin-treated diabetic and normal rats. Metabolism 47:584-591, 1998
15. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kadmar V: Physiological insulinemia acutely modulates plasma leptin. Diabetes 47:544-549, 1998
16. Mueller WM, Gregoire F, Stanhope KL, Mobbs CV, Mizuno TM, Warden CH, Stern JS, Havel PJ: Evidence that glucose metabolism regulates leptin secretion from cultured adipocytes. Endocrinology 139:551-558, 1998
17. Sipols AJ, Baskin DG, Schwartz MW: Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropoptide gene expression. Diabetes 44:147-151, 1995
18. Sindelar D, Havel P, Seeley R, Wilkinson C, Woods S, Schwartz M: Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes 48:1275-1280, 1999
19. Flier J, Maratos-Flier E: Obesity and the hypothalamus: novel peptides for new pathways. Cell 92:437-440, 1998
20. Woods S, Seeley R, Porte DJ, Schwartz M: Signals that regulate food intake and energy homeostasis. Science 280:1378-1383, 1998
21. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewiz DP: Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130:3608-3616, 1992
22. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101-1106, 1996
23. Uehara Y, Shimizu H, Ohtani K, Sato N, Mori M: Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 47:890-893, 1998
24. Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B: Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124:733-739, 1989
25. Fan W, Boston B, Kesterson R, Hruby V, Cone R: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168, 1997
26. Grill H, Ginsberg A, Seeley R, Kaplan J: Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J Neurosci 18:10128-10135, 1998
27. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U: Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5:1066-1070, 1999
28. Cone R, Lu D, Koppula S, Vage DI, Klungland H, Boston B, Chen W, Orth DN, Pouton C, Kesterson RA: The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Recent Prog Horm Res 51:287-318, 1996
29. Huszar D, Lynch C, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141, 1997
30. Schwartz M, Seeley R, Woods S, Weigle DS, Campfield LA, Burn P, Baskin DG: Leptin increases hypothalamic proopiomelanocortin (POMC) mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123, 1997
31. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV: Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 47:294-297, 1998
32. Shutter J, Graham M, Kinsey A, Scully S, Luthy R, Stark K: Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11:593-602, 1997
33. Vidal Puig A, Solanes G, Grujic D, Flier JS, Lowell BB: UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Comm 235:79-82, 1997
34. Boss O, Samee S, Paloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P, Giacobino J-P: Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408:39-42, 1997
35. Gong D, He Y, Karas M, Reitman M: Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, β3-adrenergic agonists, and leptin. J Biol Chem 272:24129-24132, 1997
36. Weigle DS, Schwartz MW, Selfridge LE, Seeley RJ, Cummings DE, Havel PJ, Kuijper JL: Elevated free fatty acids induce uncoupling protein 3 expression in muscle. Diabetes 47:298-302, 1998
37. Ahren B, Stern JS, Gingerich RL, Curry DL, Havel PJ: Glucagon secretory responses to hypoglycemia, adrenaline, and carbachol in streptozotocin diabetic rats. Acta Physiol Scand 155:215-221, 1995
38. Landt M, Gingerich RL, Havel PJ, Mueller WM, Schoner B, Hale JE, Heiman ML: Radioimmunoassay of rat leptin: sexual dimorphism reversed from humans. Clin Chem 44:565-570, 1998
39. Wilkinson C, Shinsako J, Dallman MF: Return of pituitary-adrenal function after adrenal enucleation or transplantation: diurnal rhythms and responses to ether. Endocrinology 109:162-169, 1981
40. Dallman MF: Viewing the ventromedial hypothalamus from the adrenal gland. Am J Physiol 246:R1-R12, 1984
41. Baskin DG, Seeley RJ, Kuijper JL, Lok S, Weigle DS, Erickson JC, Palmiter RD, Schwartz MW: Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. Diabetes 47:538-543, 1998
42. Baskin DG, Breininger JF, Schwartz MW: Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48:828-833, 1999
43. White JD, Olchovsky D, Kershaw M, Berelowitz M: Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 126:765-772, 1990
44. Sahu A, Sninsky CA, Kalra PS, Kalra SP: Neuropeptide Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198, 1990
45. McKibbin PE, McCarthy HD, Shaw P, Williams G: Insulin deficiency is a specific stimulus to hypothalamic neuropeptide Y: a comparison of the effects of insulin replacement and food restriction in streptozotocin-diabetic rats. Peptides 13:721-727, 1992
46. Chavez M, Seeley RJ, Havel PJ, Friedman MI, Woods SC, Schwartz MW: Effects of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes. J Clin Invest 102:340-346, 1998
47. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Early AR, Barnett AH, Prins JP, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997
48. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401, 1998
49. Keim NL, Stern JS, Havel PJ: Relationship between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr 68:794-801, 1998
50. Nishimura H, Kuzuya H, Okamoto M, Yamada K, Kosaki A, Kakehi T, Inoue G, Kono S, Imura H: Postreceptor defect in insulin action in streptozotocin-induced diabetic rats. Am J Physiol 256:E624-E630, 1989
51. Mountjoy K, Mortrud M, Low M, Simerly R, Cone R: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298-1308, 1994
52. Baker RA, Herkenham M: Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 358:518-530, 1995
53. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157, 1998
54. Yeo G, Farooqi I, Aminian S, Halsall D, Stanhope R, O'Rahilly S: A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20:111-112, 1998
55. Vaisse C, Clement K, Guy-Grand B, Froguel P: A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20: 113-114, 1998
56. Hahn TM, Breininger JF, Baskin DG, Schwartz MW: Co-localization of agouti-related protein and neuropeptide Y in arcuate nucleus neurons activated by fasting. Nature Neurosci 1:271-272, 1998
57. Broberger C, De Lecea L, Sutcliffe JG, Hokfelt T: Hypocretin/orexin-and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. J Comp Neurol 402:460-474, 1998
58. Mizuno TM, Mobbs CV: Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140:814-817, 1999
59. Cheung C, Clifton D, Steiner R: Proopimelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138:4489-4492, 1997
60. Wilson BD, Bagnol D, Kaelin CB, Ollmann MM, Gantz I, Watson SJ, Barsh GS: Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. Endocrinology 140:2387-2397, 1999
61. Dallman MF, Strack AM, Akana SF, Bradbury MJ, Hanson ES, Scribner KA, Smith M: Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14:303-347, 1993
62. Strack AM, Sebastian RJ, Schwartz MW, Dallman MF: Glucocorticoids and insulin: reciprocal signals for energy balance. Am J Physiol 268:142-149, 1985
63. Schwartz MW, Strack AM, Dallman MF: Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes. Regul Pept 72:105-112, 1997
64. Houwing H, Benthem L, Van Suylichem PT, Van der Leest J, Strubbe JH, Steffens AB: Islet transplantation in diabetic rats normalizes basal and exercise-induced energy metabolism. Diabetologia 38:919-926, 1995
65. Hidaka S, Kakuma T, Yoshimatsu H, Sakino H, Fucuchi S, Sakata T: Streptozotocin treatment upregulates uncoupling protein 3 expression in the rat heart. Diabetes 48:430-435, 1999
66. Burcelin R, Kande J, Ricquier D, Girard J: Changes in uncoupling protein and GLUT4 glucose transporter expressions in interscapular brown adipose tissue of diabetic rats: relative roles of hyperglycaemia and hypoinsulinaemia. Biochein J 291:109-113, 1993
67. Strack AM, Horsley CJ, Sebastian RJ, Akana SF, Dallman MF: Glucocorticoids and insulin: complex interaction on brown adipose tissue. Am J Physiol 268:R1209-R1216, 1995
68. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 266:R1765-R1770, 1994
69. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B: Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43:764-769, 1994
70. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL: Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33:542-547, 1999
71. Yoshitomi H, Yamazaki K, Abe S, Tanaka I: Differential regulation of mouse uncoupling proteins among brown adipose tissue, white adipose tissue, and skeletal muscle in chronic beta 3 adrenergic receptor agonist treatment. Biochem Biophys Res Commun 253:85-91, 1998
72. Kageyama H, Suga A, Kashiba M, Oka J, Osaka T, Kashiwa T, Hirano T, Nemoto K, Namba Y, Ricquier D, Giacobino JP, Inoue S: Increased uncoupling protein-2 and -3 gene expressions in skeletal muscle of STZ-induced diabetic rats. FEBS Lett 440:450-453, 1998